Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bioanalytical Syst (BASI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,896
  • Shares Outstanding, K 10,240
  • Annual Sales, $ 24,240 K
  • Annual Income, $ 880 K
  • 36-Month Beta 0.97
  • Price/Sales 0.70
  • Price/Cash Flow 5.31
  • Price/Book 1.59

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.57 +7.64%
on 09/06/18
1.88 -10.11%
on 08/27/18
+0.05 (+3.05%)
since 08/21/18
3-Month
1.45 +16.55%
on 08/15/18
2.59 -34.75%
on 07/02/18
+0.10 (+6.29%)
since 06/21/18
52-Week
1.37 +23.36%
on 04/04/18
2.95 -42.71%
on 12/11/17
-0.03 (-1.74%)
since 09/21/17

Most Recent Stories

More News
Bioanalytical Systems to Release Third Quarter Fiscal 2018 Results on Tuesday, August 14, 2018

Bioanalytical Systems, Inc. (NASDAQ:BASI) ("BASi" or the "Company") announced today that it will report financial results for the third quarter and nine months ended June 30, 2018, prior to the market...

BASI : 1.69 (+2.42%)
BASi Announces Appointment of John E. Sagartz to Board of Directors

Bioanalytical Systems, Inc. (NASDAQ:BASI) has announced that its Board of Directors agreed unanimously on July 2, 2018, to appoint John E. Sagartz, DVM, PhD, DACVP, as a director.

BASI : 1.69 (+2.42%)
BASi and Seventh Wave Laboratories Combine Operations to Provide Broader Solutions and Greater Scientific Expertise to Clients

Bioanalytical Systems, Inc. (NASDAQ:BASI) and Seventh Wave Laboratories, LLC, today announced that they have signed an asset purchase agreement (APA) joining operations to provide broader solutions and...

BASI : 1.69 (+2.42%)
BASi and Phlebotics Form Strategic Alliance; Continuing a Commitment to Automated Blood Sampling

WEST LAFAYETTE, IN / ACCESSWIRE / April 4, 2018 / Bioanalytical Systems, Inc. (NASDAQ: BASI) ("BASi" or the "Company") today announced a technology alliance with Phlebotics, Inc. This agreement is the...

BASI : 1.69 (+2.42%)
Bolstering Preclinical PK/PD Operations: BASi Hires Karen L. Rogers, DVM, DACLAM, CPIA as Attending Veterinarian

WEST LAFAYETTE, IN / ACCESSWIRE / March 27, 2018 / Bioanalytical Systems, Inc. (NASDAQ: BASI) ("BASi" or the "Company") today announced the addition of Dr. Karen L. Rogers as Attending Veterinarian, Preclinical...

BASI : 1.69 (+2.42%)
Gaining Momentum: BASi Adds Candace Rohde-Johnson as Director of in Vivo Products and Services

WEST LAFAYETTE, IN / ACCESSWIRE / October 3, 2017 / Bioanalytical Systems, Inc. (NASDAQ: BASI) ("BASi" or the "Company")today announced the addition of Candace Rohde-Johnson as Director of In Vivo Products...

BASI : 1.69 (+2.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade BASI with:

Business Summary

Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product...

See More

Key Turning Points

2nd Resistance Point 1.74
1st Resistance Point 1.71
Last Price 1.69
1st Support Level 1.64
2nd Support Level 1.60

See More

52-Week High 2.95
Fibonacci 61.8% 2.35
Fibonacci 50% 2.16
Fibonacci 38.2% 1.97
Last Price 1.69
52-Week Low 1.37

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar